Preston C Sprenkle
Overview
Explore the profile of Preston C Sprenkle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
351
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sundaresan V, Webb L, Rabil M, Golos A, Sutherland R, Bailey J, et al.
Urol Oncol
. 2024 Dec;
43(3):193.e19-193.e26.
PMID: 39706698
Background And Objective: As most Prostate Imaging Reporting and Data System (PI-RADS) 5 lesions on MRI harbor Gleason grade (GG) group ≥2 disease on biopsy, optimal management of patients with...
2.
Rahman S, Kim H, Webb L, Diaz G, Leapman M, Sprenkle P, et al.
Transl Cancer Res
. 2024 Dec;
13(11):6473-6488.
PMID: 39697737
Radiation- (radio-)recurrent prostate cancer poses a significant challenge in clinical management due to its complexity and varied treatment responses. The recurrence of prostate cancer following radiotherapy necessitates a nuanced management...
3.
Lokeshwar S, Choksi A, Smani S, Kong V, Sundaresan V, Sutherland R, et al.
Urol Oncol
. 2024 Nov;
PMID: 39521675
Background And Objective: Comparative studies among biopsy strategies have not been conducted evaluating pathologic concordance at radical prostatectomy(RP), especially with novel micro-ultrasound (micro-US) image-guided biopsy. Methods: A retrospective study among...
4.
Press B, Lokeshwar S, Webb L, Khajir G, Smani S, Olawoyin O, et al.
Explor Target Antitumor Ther
. 2024 Oct;
5(6):1168-1176.
PMID: 39465014
Aim: Prostate biopsy can be prone to complications and thus should be avoided when unnecessary. Although the combination of magnetic resonance imaging (MRI), the prostate health index (PHI), and PHI...
5.
Kunst N, Long J, Westvold S, Sprenkle P, Kim I, Saperstein L, et al.
JAMA Netw Open
. 2024 Oct;
7(10):e2440591.
PMID: 39441595
Importance: Although prostate-specific membrane antigen positron emission tomography (PSMA-PET) has shown improved sensitivity and specificity compared with conventional imaging for the detection of biochemical recurrent (BCR) prostate cancer, the long-term...
6.
Smani S, Jalfon M, Sundaresan V, Lokeshwar S, Nguyen J, Halstuch D, et al.
Urol Oncol
. 2024 Oct;
PMID: 39438211
Importance: The Prostate Imaging Reporting & Data System (PI-RADS) scoring guidelines were developed to address the substantial variation in interpretation and reporting of prostate cancer (PCa) multiparametric MRI (mpMRI) results,...
7.
Sundaresan V, Wang R, Long J, Sprenkle P, Seibert T, Loeb S, et al.
Urol Pract
. 2024 Aug;
11(6):965-973.
PMID: 39196719
Introduction: Although prostate MRI and tissue-based gene expression (genomic) tests improve staging and estimates of prostate cancer prognosis, their association with the intensity of treatment patients receive is not well...
8.
Leapman M, Ho J, Liu Y, Filson C, Zhao X, Hakansson A, et al.
Eur Urol Oncol
. 2024 Aug;
PMID: 39098389
Background And Objective: Although the prognostic significance of the Decipher prostate cancer genomic classifier (GC) has been established largely from analyses of archival tissue, less is known about the associations...
9.
Kim Jr I, Wang A, Corpuz G, Sprenkle P, Leapman M, Brito J, et al.
Prostate Int
. 2024 Jul;
12(2):70-78.
PMID: 39036758
Introduction: Although the clinical benefits of pelvic lymph node dissection (PLND) at the time of radical prostatectomy for prostate cancer remain uncertain, major guidelines recommend PLND based on risk profile....
10.
Sundaresan V, Smani S, Rajwa P, Renzulli J, Sprenkle P, Kim I, et al.
Urol Oncol
. 2024 Jul;
43(1):41-48.
PMID: 39019723
Prostate specific antigen (PSA) has transformed the diagnosis and treatment of prostate cancer by enabling early detection at global scale. Due to expression in both benign and malignant cells, PSA-based...